These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 8896550
21. Frequency of the C282Y mutation of hemochromatosis in five French populations. Mercier G, Bathelier C, Lucotte G. Blood Cells Mol Dis; 1998 Jun; 24(2):165-6. PubMed ID: 9642097 [Abstract] [Full Text] [Related]
23. An association between the common hereditary hemochromatosis mutation and the factor V Leiden allele in a population with thrombosis. Xie YG, Lillicrap DP, Taylor SA. Blood; 1998 Aug 15; 92(4):1461-2. PubMed ID: 9694741 [No Abstract] [Full Text] [Related]
24. The significance of the 187G (H63D) mutation in hemochromatosis. Beutler E. Am J Hum Genet; 1997 Sep 15; 61(3):762-4. PubMed ID: 9326341 [No Abstract] [Full Text] [Related]
25. Haemochromatosis gene C282Y homozygotes in an elderly male population. Willis G, Wimperis JZ, Smith KC, Fellows IW, Jennings BA. Lancet; 1999 Jul 17; 354(9174):221-2. PubMed ID: 10421310 [Abstract] [Full Text] [Related]
30. Two novel polymorphisms (E277K and V212V) in the haemochromatosis gene HFE. Bradbury R, Fagan E, Payne SJ. Hum Mutat; 2000 Jan 23; 15(1):120. PubMed ID: 10612845 [No Abstract] [Full Text] [Related]
31. Haemochromatosis: strike while the iron is hot. Cox T. Nat Genet; 1996 Aug 23; 13(4):386-8. PubMed ID: 8696327 [No Abstract] [Full Text] [Related]
32. Incorrect diagnosis of hereditary hemochromatosis. Mirochnik O, Halim-Kertanegara N, Hertzberg M, McDonald D, Liddle C. Am J Hematol; 2000 Feb 23; 63(2):104-5. PubMed ID: 10629581 [No Abstract] [Full Text] [Related]
33. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Willis G, Jennings BA, Goodman E, Fellows IW, Wimperis JZ. Blood Cells Mol Dis; 1997 Aug 23; 23(2):288-91. PubMed ID: 9410472 [Abstract] [Full Text] [Related]
34. Cardiac hemochromatosis in an HFE His63Asp (187C->G) heterozygote. Winer D, Silversides C, Israel N, Rinne C, Chang WS, Butany J. Can J Cardiol; 2004 Aug 23; 20(10):971-2. PubMed ID: 15332145 [No Abstract] [Full Text] [Related]
35. Clinical implications of the hemochromatosis gene. Tavill AS. N Engl J Med; 1999 Sep 02; 341(10):755-7. PubMed ID: 10471465 [No Abstract] [Full Text] [Related]
36. Population screening for hemochromatosis. Adams PC. Hepatology; 1999 Apr 02; 29(4):1324-7. PubMed ID: 10094982 [No Abstract] [Full Text] [Related]
37. No age-related decrease in frequency of heterozygotes for the HFE C282Y haemochromatosis mutation. Waalen J, Beutler E. J Hepatol; 2004 Jun 02; 40(6):1044; author reply 1044-5. PubMed ID: 15158353 [No Abstract] [Full Text] [Related]
38. Diagnosis and management of haemochromatosis since the discovery of the HFE gene: a European experience. Br J Haematol; 2000 Jan 02; 108(1):31-9. PubMed ID: 10651721 [No Abstract] [Full Text] [Related]
39. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Gomez PS, Parks S, Ries R, Tran TC, Gomez PF, Press RD. Nat Genet; 1999 Nov 02; 23(3):272. PubMed ID: 10545944 [No Abstract] [Full Text] [Related]
40. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Noll WW, Belloni DR, Stenzel TT, Grody WW. Nat Genet; 1999 Nov 02; 23(3):271-2. PubMed ID: 10610176 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]